Eyewire News: The Podcast

Eyewire News
  • 5.0 (1)
  • BUSINESS NEWS
  • UPDATED WEEKLY

Eyewire News: The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and other news sources.

  1. 6D AGO

    Study: Metformin May Lower AMD Progression

    New research reveals that a popular diabetes treatment may lower the risk of AMD progression; a study examines the performance of large language models on specialty ophthalmology examinations; and a new doctor-led alliance that aims to support private practice optometrists has officially launched.  Learn more about your ad choices. Visit megaphone.fm/adchoices

    5 min

  2. FEB 4

    First Dual-Agent Eye Drop for Presbyopia Approved

    The FDA approves the first dual-agent eye drop for presbyopia; Rayner launches a personalized, AI-powered patient education platform; and new study examines the link between sleep positioning and eye pressure.  Learn more about your ad choices. Visit megaphone.fm/adchoices

    7 min

  3. JAN 28

    FDA Approves Label Supplement for iDose TR

    The FDA approves a key label supplement for Glaukos’ iDoseTR; Nidek announces the European launch of a new open-field refraction system; and there have been several leadership changes announced during the first month of 2026. Learn more about your ad choices. Visit megaphone.fm/adchoices

    6 min

  4. JAN 21

    Rayner Launches New Phaco System

    Rayner launches a new phaco system in the US; Eylea 8 mg is approved for a third indication in Europe; and Nanodropper announces a consolidation plan to expand its offerings under a new name.  Learn more about your ad choices. Visit megaphone.fm/adchoices

    4 min

  5. JAN 14

    Moorfields Researchers Reveal Promising Treatment for Hypotony

    New research may provide hope for patients with a rare vision-threatening condition; the first daily disposable soft contact lens using EDOF technology for presbyopia is cleared in the US; and there several advancements made in the clinical development of treatment candidates for retinal diseases. Learn more about your ad choices. Visit megaphone.fm/adchoices

    10 min

  6. JAN 7

    Staar Terminates Merger with Alcon

    Shareholders vote on Alcon’s blockbuster acquisition proposal for Staar Surgical; the FDA responds to Outlook’s latest BLA submission for wet AMD drug Lytenava; and the FDA approves an interchangeable biosimilar to Lucentis.  Learn more about your ad choices. Visit megaphone.fm/adchoices

    12 min

  7. 12/31/2025

    2025 Year in Review - Part 2

    Highlights from the last 6 months of 2025 include advancements of emerging technologies in glaucoma, the first pharmacologic treatment for myopia in Europe, the expansion of labels for anti-VEGF treatments, and the release of the DEWS III report exploring the diagnosis and management of dry eye disease.  Learn more about your ad choices. Visit megaphone.fm/adchoices

    9 min

  8. 12/24/2025

    2025 Year in Review - Part 1

    There were several advancements made during the first 6 months of 2025, including the first FDA approval for neurodegenerative disease MacTel; the approval of a first-of-its-kind drug for dry eye disease; advancements in premium IOLs; the approval of an excimer laser platform, and the launch of a new presbyopia drop. Learn more about your ad choices. Visit megaphone.fm/adchoices

    10 min
See All (80)

About

Eyewire News: The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and other news sources.

Information

  • Creator
    Eyewire News
  • Years Active
    2024 - 2026
  • Episodes
    80
  • Rating
    Clean

You Might Also Like